Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design Study.
Irene PetersenSia Kromann NicolaisenFederico RicciardiManuj SharmaReimar Wernich ThomsenGianluca BaioLars PedersenPublished in: Clinical epidemiology (2020)
Individuals with first record of HbA1c measure just above treatment threshold experienced a 21% lower rate of death or CVE than those just below. Lifestyle modifications and cardiovascular risk-factor management may contribute to this reduced rate.